Summary
Definition
History and exam
Key diagnostic factors
- vision loss or visual field deficit
- weakness
- aphasia
- ataxia (impaired coordination)
Other diagnostic factors
- history of transient ischemic attack (TIA)
- sudden onset of symptoms
- negative symptoms (i.e., loss of function)
- altered sensation
- headache
- diplopia
- sensory loss
- dysarthria
- "Crossed" syndromes
- gaze paresis
- arrhythmias, murmurs, or pulmonary edema
- vertigo/dizziness
- nausea and/or vomiting
- neck or facial pain
- miosis, ptosis, and facial anhidrosis (hemilateral)
- altered level of consciousness/coma
- confusion
Risk factors
- hypertension
- older age
- sickle cell disease
- family history of stroke
- history of transient ischemic attack (TIA)
- history of ischemic stroke
- cerebral microbleeds
- smoking
- diabetes mellitus
- atrial fibrillation
- comorbid cardiac conditions
- carotid artery stenosis
- intracranial atherosclerosis (ICAS)
- dyslipidemia
- lower levels of education
- ethnicity
- poor diet and nutrition
- low birth weight
- physical inactivity
- obesity
- alcohol misuse
- use of oral estrogen-containing therapy
- pregnancy
- migraine
- severe obstructive sleep apnea
- long sleep duration and poor sleep quality
- illicit drug use
- hyperhomocysteinemia
- elevated lipoprotein(a)
- hypercoagulable states
- elevated C-reactive protein
- aortic arch plaques
- patent foramen ovale (PFO)
- air pollution
- e-cigarettes
- infections
- endometriosis
Diagnostic investigations
1st investigations to order
- CT head
- MRI brain
- CT angiography or magnetic resonance angiography
- CT or MRI perfusion
- serum glucose
- serum electrolytes
- serum BUN and creatinine
- cardiac enzymes
- ECG
- CBC
- coagulopathy screen
Investigations to consider
- serum toxicology screen
- infection screen
- genetic testing
- CXR
- CT or magnetic resonance or digital subtraction venography
- carotid ultrasound
- echocardiogram
- transcranial Doppler ultrasound
- conventional (invasive) angiography
Treatment algorithm
without cerebral venous sinus thrombosis
with cerebral venous sinus thrombosis
Contributors
Authors
David Wang, DO, FAHA, FAAN
Professor of Neurology
Co-Director
Petznick Stroke Center
Neurovascular Division
Barrow Neurological Institute
Phoenix
AZ
Disclosures
DW received honorarium from Boehringer Ingelheim for lectures on the use of thrombolytics for acute ischemic stroke. He has also received honorarium from Amgen, Zhongmei Huadong, and ShiYao Pharmaceuticals for speaking. DW was Chair, Stroke Section of the American Academy of Neurology, 2017-2019. He was Chair, Quality and Safety Subcommittee of the American Academy of Neurology (term ended June 2018). DW is an author of references cited in this topic.
Yi Dong, MD, PhD
Department of Neurology
Huashan Hospital
Fudan University
Shanghai
China
Disclosures
YD declares that she has no competing interests.
Yilong Wang, MD, PhD
Professor of Neurology
Deputy Director, Department of Neurology
Beijing Tiantan Hospital, Capital Medical University
Beijing
China
Disclosures
YW declares that he has no competing interests.
Acknowledgements
Dr David Wang, Dr Yi Dong, and Dr Yilong Wang would like to gratefully acknowledge Dr George Ntaios and Dr Alireza Minagar, the previous contributors to this topic.
Disclosures
GN is on the advisory boards for, and has received honoraria, speaker fees, and research support from: Amgen, Bayer, Boehringer-Ingelheim, BMS/Pfizer, Elpen, Galenica, Medtronic, Sanofi, and Winmedica. AM declares that he has no competing interests.
Peer reviewers
Nishant K. Mishra, MD, PhD, FRCP, FAHA
Assistant Professor of Neurology
Yale University
New Haven
CT
Disclosures
NM declares that he has no competing interests.
Julien Morier, MD
Neurology Registrar
Neurology Service
Centre Hospitalier Universitaire Vaudois (CHUV)
Lausanne
Switzerland
Disclosures
JM declares that he has no competing interests.
Louis R. Caplan, MD
Lecturer in Neurology
Hospital Chief
Cerebrovascular/Stroke Division
Beth Israel Deaconess Medical Center
Division of Cerebrovascular/Stroke
Boston
MA
Declarações
LRC declares that he has no competing interests.
Tony Rudd, MD
National Clinical Director
Stroke NHS England
Professor, Stroke Medicine
Kings College London
Chair, Intercollegiate Stroke Working Party
Royal College of Physicians
London
UK
Declarações
TR declares that he has no competing interests.
Referências
Principais artigos
Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke. 2021 Jul;52(7):e364-467.Texto completo Resumo
Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019 Dec;50(12):e344-418.Texto completo Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Diagnósticos diferenciais
- Intracerebral hemorrhage
- Transient ischemic attack
- Transient global amnesia
Mais Diagnósticos diferenciaisDiretrizes
- Diagnosis and management of cerebral venous thrombosis: a scientific statement from the American Heart Association
- European Stroke Organisation (ESO) - European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischaemic stroke
Mais DiretrizesFolhetos informativos para os pacientes
Stroke: treatment
Feeding tube insertion
Mais Folhetos informativos para os pacientesCalculadoras
NIH Stroke Score
ABCD2 Score to Predict Stroke Risk after TIA
Mais CalculadorasVideos
Tracheal intubation: animated demonstration
Bag-valve-mask ventilation: animated demonstration
Mais vídeos
Conectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal